• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Contrast unavailability in U.S. harms diagnostic ultrasound

Article

"We have so many CT and MR machines in the U.S. providing quick, easy, and efficient imaging that it's hard for ultrasound to compete, especially when it comes down to physicians' time.

"We have so many CT and MR machines in the U.S. providing quick, easy, and efficient imaging that it's hard for ultrasound to compete, especially when it comes down to physicians' time.

"I don't think any radiologist would be happy to give a final diagnosis on metastatic disease in the liver using CT or MRI without a contrast agent. We do not have the advantage of using contrast agents with ultrasound in this country, since they have not been approved by the FDA.

"Having contrast agents readily available will help improve ultrasound's diagnostic capabilities in many ways, including bedside imaging of patients who cannot be transported. One of the AIUM's new initiatives is to work with the FDA to accelerate the approval process."

-Lennard Greenbaum, M.D., president of the American Institute of Ultrasound in Medicine, speaking at the AIUM meeting in June

Recent Videos
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.